Menu

Events & Presentations

Panbela Announces Oral Presentation at Digestive Disease Week (DDW)

Evaluation of the Safety and Efficacy of Eflornithine (Difluoromethylornithine, DFMO) in Patients with Gastric Premalignant Conditions in the High Incidence Areas of Latin America

Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week (DDW)

Panbela Announces Poster Presentation at American Association for Cancer Research

Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models

Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)

Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication

Panbela to Present at the LD Micro Investor Conference

Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference

Panbela Announces Poster Presentation at the Endocrine Society Meeting

Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes

Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting

Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes

Panbela Announces Poster Presentation at American Association for Cancer Research

Evaluating the potential of spermine analogue ivospemin (SBP-101) in combination with chemotherapy in ovarian cancer

Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Immunology of Diabetes Society Meeting

Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Endocrine Society Meeting

Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)

Panbela to Host Virtual R&D Day

Panbela Announces Poster Presentation at American Association for Cancer Research: The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancer

Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28 at 12pm ET

Panbela to Participate in the 34th Annual Roth Conference

Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting

Interim data presented in poster reflects median overall survival of 12.0 months, not yet final, and an objective response rate of 48%, both greater than historical rates reported for standard of care

Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Panbela to Present at Upcoming Investor Conferences

H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23

Panbela to Present at Access to Giving Virtual Conference July 15 at 10:30 a.m. ET

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting

SBP Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium

  • SBP-101 was well tolerated in combination with gemcitabine and nab-paclitaxel
  • Objective Response Rate (ORR) was 62% by RECIST criteria
  • Study expansion in patients with pancreatic cancer planned to begin in Q2

View/download press release »
View/download poster presentation »

SBP to Present Results of New Study at American Pancreatic Association Meeting

New study entitled “Effect of SBP-101 in a Mouse Model of Cerulein-induced Acute Pancreatitis” will be presented at the American Pancreatic Association meeting in Miami, FL on Nov. 1.

View/download press release »
View/download poster presentation »

PancreasFest 2015

Sun BioPharma participated in the poster session at PancreasFest on 22-24 July 2015 in Pittsburgh, PA.

A joint meeting of physicians and scientists committed to learning and collaborating on translational studies of pancreatic diseases.

For more information, please visit their website at pancreasfest.com